Artemisinin Antimalarial Drugs Market
According to Intent Market Research, the Artemisinin Antimalarial Drugs Market is expected to grow from USD 0.6 billion in 2023 at a CAGR of 5.8% to touch USD 0.8 billion by 2030. The Artemisinin Antimalarial Drugs Market is dominated by key players such as Novartis AG, Sanofi, Cipla Inc., IPCA Laboratories, Guilin Pharmaceutical Co. Ltd., Strides Pharma Science Limited, KPC Pharmaceuticals, Inc., Mylan N.V. (now part of Viatris), F. Hoffmann-La Roche AG, Ranbaxy Laboratories (now part of Sun Pharma), Ajanta Pharma Ltd., GlaxoSmithKline (GSK), Pfizer Inc., Bayer AG, Jiangsu Shenhua Pharmaceutical Co. Ltd.